Comparative study of ketoconazole and itraconazole in pityriasis versicolor
V K Jain
Department of Skin, V.D. and Leprosy, Pt. B.D.S. PGIMS, Rohtak-124 001
|How to cite this article:
Jain V K, Aggarwal K. Comparative study of ketoconazole and itraconazole in pityriasis versicolor. Indian J Dermatol Venereol Leprol 1999;65:267-266
Forty patients with pityriasis versicolor were treated with either oral ketoconazole, 200mg per day for 5 days ( 20 patients) or oral itraconazole, 200mg per day for 5 days (20 patients). On global assessment after 2 weeks, 17 ( 85%) out of 20 patients treated with oral ketoconazole were cured while 3 cases had considerable residual lesions. In oral itraconazole-treated group, 19 (95%) out of 20 patients were cured and one case still had considerable residual lesions. No significant difference was observed in response rates in the two groups. Relapse occurred in 3 patients of ketoconazole group and 1 patient of itraconazole group during the follow-up period of 4 months.